Trial
NCT04152018
Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Pfizer
Collaborators
—
Condition
Squamous Cell Carcinoma of the Head and Neck
Intervention
PF-06940434
Why stopped
Study termination was based on strategic considerations and not due to specific safety reasons or a request from a regulatory authority.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-28